Morabito Christopher 4
4 · Fulcrum Therapeutics, Inc. · Filed May 12, 2021
Insider Transaction Report
Form 4
Morabito Christopher
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2021-05-10+163,000→ 163,000 totalExercise: $10.01Exp: 2031-05-09→ Common Stock (163,000 underlying)
Footnotes (1)
- [F1]This option was granted on May 10, 2021 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of May 10, 2021. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.